Surmodics Inc (SRDX)
32.49
-2.06
(-5.96%)
USD |
NASDAQ |
May 03, 16:00
32.57
+0.08
(+0.25%)
After-Hours: 20:00
Surmodics Enterprise Value: 456.80M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 456.80M |
| May 02, 2024 | 486.12M |
| May 01, 2024 | 468.75M |
| April 30, 2024 | 359.99M |
| April 29, 2024 | 362.27M |
| April 26, 2024 | 366.83M |
| April 25, 2024 | 366.83M |
| April 24, 2024 | 365.40M |
| April 23, 2024 | 377.50M |
| April 22, 2024 | 355.72M |
| April 19, 2024 | 371.38M |
| April 18, 2024 | 369.96M |
| April 17, 2024 | 371.81M |
| April 16, 2024 | 372.95M |
| April 15, 2024 | 370.38M |
| April 12, 2024 | 378.64M |
| April 11, 2024 | 388.32M |
| April 10, 2024 | 387.75M |
| April 09, 2024 | 389.32M |
| April 08, 2024 | 385.62M |
| April 05, 2024 | 379.78M |
| April 04, 2024 | 381.20M |
| April 03, 2024 | 378.07M |
| April 02, 2024 | 378.21M |
| April 01, 2024 | 391.45M |
| Date | Value |
|---|---|
| March 28, 2024 | 411.95M |
| March 27, 2024 | 404.27M |
| March 26, 2024 | 395.87M |
| March 25, 2024 | 384.90M |
| March 22, 2024 | 388.04M |
| March 21, 2024 | 396.58M |
| March 20, 2024 | 404.55M |
| March 19, 2024 | 389.89M |
| March 18, 2024 | 385.33M |
| March 15, 2024 | 395.30M |
| March 14, 2024 | 397.29M |
| March 13, 2024 | 406.83M |
| March 12, 2024 | 412.24M |
| March 11, 2024 | 413.52M |
| March 08, 2024 | 430.89M |
| March 07, 2024 | 423.48M |
| March 06, 2024 | 418.36M |
| March 05, 2024 | 426.05M |
| March 04, 2024 | 444.70M |
| March 01, 2024 | 450.82M |
| February 29, 2024 | 448.40M |
| February 28, 2024 | 457.79M |
| February 27, 2024 | 467.76M |
| February 26, 2024 | 463.77M |
| February 23, 2024 | 461.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
245.03M
Minimum
Mar 23 2023
771.71M
Maximum
Nov 08 2021
512.93M
Average
499.93M
Median
Jun 23 2022
Enterprise Value Benchmarks
| Boston Scientific Corp | 115.63B |
| ResMed Inc | 32.64B |
| Glaukos Corp | 5.375B |
| Accuray Inc | 262.66M |
| Alphatec Holdings Inc | 2.175B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.786M |
| Revenue (Quarterly) | 30.55M |
| Total Expenses (Quarterly) | 30.87M |
| EPS Diluted (Quarterly) | -0.06 |
| Gross Profit Margin (Quarterly) | 42.83% |
| Profit Margin (Quarterly) | -2.57% |
| Earnings Yield | 1.17% |
| Operating Earnings Yield | 2.74% |
| Normalized Earnings Yield | 1.172 |